ZA895710B - The use of imexon as immune suppressive and pharmaceutical compositions containing imexon - Google Patents
The use of imexon as immune suppressive and pharmaceutical compositions containing imexonInfo
- Publication number
- ZA895710B ZA895710B ZA895710A ZA895710A ZA895710B ZA 895710 B ZA895710 B ZA 895710B ZA 895710 A ZA895710 A ZA 895710A ZA 895710 A ZA895710 A ZA 895710A ZA 895710 B ZA895710 B ZA 895710B
- Authority
- ZA
- South Africa
- Prior art keywords
- imexon
- pharmaceutical compositions
- compositions containing
- immune suppressive
- cell
- Prior art date
Links
- BIXBBIPTYBJTRY-UHFFFAOYSA-N imexon Chemical compound NC1=NC(=O)N2CC12 BIXBBIPTYBJTRY-UHFFFAOYSA-N 0.000 title abstract 6
- 229950003978 imexon Drugs 0.000 title abstract 5
- 230000006028 immune-suppresssive effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000001991 pathophysiological effect Effects 0.000 abstract 1
- 208000031223 plasma cell leukemia Diseases 0.000 abstract 1
- 208000010626 plasma cell neoplasm Diseases 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3825667A DE3825667A1 (de) | 1988-07-28 | 1988-07-28 | Verwendung von imexon als immunsuppressivum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA895710B true ZA895710B (en) | 1990-04-25 |
Family
ID=6359767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA895710A ZA895710B (en) | 1988-07-28 | 1989-07-27 | The use of imexon as immune suppressive and pharmaceutical compositions containing imexon |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0352652B1 (enExample) |
| JP (1) | JP2848634B2 (enExample) |
| KR (1) | KR0135757B1 (enExample) |
| AT (1) | ATE117551T1 (enExample) |
| AU (1) | AU619027B2 (enExample) |
| CA (1) | CA1333771C (enExample) |
| DE (2) | DE3825667A1 (enExample) |
| DK (1) | DK175199B1 (enExample) |
| HU (1) | HU206827B (enExample) |
| IE (1) | IE66680B1 (enExample) |
| IL (1) | IL91138A (enExample) |
| PH (1) | PH26684A (enExample) |
| PT (1) | PT91293B (enExample) |
| ZA (1) | ZA895710B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200604579B (en) * | 2003-12-08 | 2007-10-31 | Univ Arizona | Synergistic anti-cancer compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2528460A1 (de) * | 1975-06-26 | 1977-01-13 | Boehringer Mannheim Gmbh | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans |
| DE2530398A1 (de) * | 1975-07-08 | 1977-01-27 | Boehringer Mannheim Gmbh | Organische verbindung |
| DE2736296A1 (de) * | 1977-08-12 | 1979-02-22 | Boehringer Mannheim Gmbh | Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung |
-
1988
- 1988-07-28 DE DE3825667A patent/DE3825667A1/de active Granted
-
1989
- 1989-07-21 PH PH38984A patent/PH26684A/en unknown
- 1989-07-21 AT AT89113425T patent/ATE117551T1/de not_active IP Right Cessation
- 1989-07-21 EP EP89113425A patent/EP0352652B1/de not_active Expired - Lifetime
- 1989-07-21 DE DE58908926T patent/DE58908926D1/de not_active Expired - Fee Related
- 1989-07-21 DK DK198903633A patent/DK175199B1/da not_active IP Right Cessation
- 1989-07-24 AU AU38877/89A patent/AU619027B2/en not_active Ceased
- 1989-07-25 CA CA000606620A patent/CA1333771C/en not_active Expired - Fee Related
- 1989-07-27 IL IL9113889A patent/IL91138A/en not_active IP Right Cessation
- 1989-07-27 IE IE244889A patent/IE66680B1/en not_active IP Right Cessation
- 1989-07-27 HU HU893821A patent/HU206827B/hu not_active IP Right Cessation
- 1989-07-27 ZA ZA895710A patent/ZA895710B/xx unknown
- 1989-07-27 PT PT91293A patent/PT91293B/pt not_active IP Right Cessation
- 1989-07-28 JP JP1194417A patent/JP2848634B2/ja not_active Expired - Fee Related
- 1989-07-28 KR KR1019890010705A patent/KR0135757B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PH26684A (en) | 1992-09-15 |
| DK363389A (da) | 1990-01-29 |
| DE3825667C2 (enExample) | 1991-06-27 |
| IL91138A0 (en) | 1990-03-19 |
| HU206827B (en) | 1993-01-28 |
| IE892448L (en) | 1990-01-28 |
| HUT52378A (en) | 1990-07-28 |
| AU619027B2 (en) | 1992-01-16 |
| KR900001369A (ko) | 1990-02-27 |
| PT91293A (pt) | 1990-02-08 |
| IL91138A (en) | 1994-10-21 |
| IE66680B1 (en) | 1996-01-24 |
| EP0352652A3 (de) | 1991-09-04 |
| KR0135757B1 (ko) | 1998-04-23 |
| DE3825667A1 (de) | 1990-03-15 |
| ATE117551T1 (de) | 1995-02-15 |
| AU3887789A (en) | 1990-02-01 |
| EP0352652A2 (de) | 1990-01-31 |
| DE58908926D1 (de) | 1995-03-09 |
| CA1333771C (en) | 1995-01-03 |
| JP2848634B2 (ja) | 1999-01-20 |
| EP0352652B1 (de) | 1995-01-25 |
| PT91293B (pt) | 1995-03-01 |
| DK363389D0 (da) | 1989-07-21 |
| DK175199B1 (da) | 2004-07-05 |
| JPH0288521A (ja) | 1990-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marslen-Wilson | Access and integration: Projecting sound onto meaning. | |
| AU7405387A (en) | Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof | |
| GR3031659T3 (en) | Enniatines and enniatine derivates used to control endoparasites. | |
| EP0573423A4 (en) | Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof | |
| EP0261224A4 (en) | SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE. | |
| NO180677C (no) | Anvendelse av (S)-(+)-hydroksyklorokin for fremstilling av legemidler | |
| HUT63063A (en) | Process for producing antibodies against cd44 cell surface glycoprotein and immunosuppressant pharmaceutical compositions comprising same | |
| IL104261A (en) | Azacyclic and azabicyclic compounds, their preparation and pharmaceutical compositions comprising them | |
| PT86362A (en) | Process for the preparation of anxiolytic compositions containing n-(1-azabicyclo ]2,2.2."-oct-3-yl) benzamides and thiobenzamides | |
| PT84258A (en) | Process for the preparation of cross-protective human monoclonal antibodies and of pharmaceutical compositions containing the same | |
| MY106231A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones. | |
| AR242561A1 (es) | Procedimiento para la preparacion de clorhidrato de s-(-)-1-propil-2',6'-pipecoloxilidida opticamente sustancialmente puro y procedimiento | |
| HU9200107D0 (en) | Process for preventing or treating autoimmun uveoretinitis in mammals | |
| UA27055C2 (uk) | Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату | |
| CA2094275A1 (en) | Methods and compositions for the treatment of cell proliferation disorders | |
| BG93298A (bg) | Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни | |
| CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
| IL91138A0 (en) | Immunosuppressive pharmaceutical compositions comprising imexon | |
| IL99233A0 (en) | Phosphonopyrrolidine-and phosphonopiperidine-containing pseudopeptides of the statin type,their preparation and pharmaceutical compositions containing them | |
| HU903011D0 (en) | Process for the preparation of cyclopeptides and pharmaceutical compositions containing them | |
| NO902934L (no) | Fremgangsmaate for fremstilling av 4h-indolo(1,2-d)(1,2,4)-triazolo(4,3-a)(1,4)benzodiazepiner, samt anvendelse som medikamenter. | |
| MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
| FR2706303B1 (fr) | Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson. | |
| GB2004183A (en) | Compositions containing caffeine and ephedrine or their derivatives | |
| ES2096559T3 (es) | Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso. |